Treace Medical Concepts, Inc (TMCI) Stock Analysis
Verdict: WATCH (do not buy)
Aggressive CEO buying and 79.5% gross margins support a bottom, but revenue contraction and cash burn keep TMCI locked in a turn-around Watch.
Investment score: 52/100
Analysis as of
Is Treace Medical Concepts, Inc stock worth reviewing? The TradeMates thesis
The model views TMCI as a speculative turnaround play. While 79.5% gross margins and persistent open-market purchases by CEO John Treace provide valuation support, negative operating margins (-26.2%) and revenue contraction prohibit a Buy rating.
7-factor investment score
- Valuation: 55/100 (weight 20%)
- Financial Health: 35/100 (weight 15%)
- Technical Momentum: 52/100 (weight 15%)
- Earnings Quality: 58/100 (weight 15%)
- Insider Sentiment: 88/100 (weight 10%)
- Analyst Consensus: 35/100 (weight 10%)
- Risk-Adjusted Return: 45/100 (weight 15%)
Treace Medical Concepts, Inc opportunities and risks
What speaks for TMCI
- Aggressive Open-Market CEO Buying
What speaks against TMCI
- Persistent Revenue Contraction & Mix Shift
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| TMCI | n/a | 1.3x | n/a | 79.5% | -29.0% | -9.3% |
| CLPT | n/a | 7.0x | n/a | 62.6% | -81.8% | -10.6% |
| MOBI | n/a | 10.8x | n/a | 82.8% | -151.6% | -12.6% |
| ELMD | 20.5x | 3.1x | 13.9x | 78.5% | 15.3% | 4.0% |
| PDEX | 14.2x | 2.5x | 10.2x | 31.4% | 17.6% | 3.6% |
| Peer median | 4.6x | 5.1x | 3.6x | 70.6% | -33.2% | -3.5% |
Frequently asked questions about Treace Medical Concepts, Inc (TMCI)
Is TMCI stock a good investment?
The TradeMates model rates Treace Medical Concepts, Inc as WATCH (do not buy) with an investment score of 52/100. The model views TMCI as a speculative turnaround play. While 79.5% gross margins and persistent open-market purchases by CEO John Treace provide valuation support, negative operating margins (-26.2%) and revenue contraction prohibit a Buy rating. This is algorithmic model output, not personal investment advice.
Is TMCI stock a buy?
The TradeMates model verdict for TMCI is WATCH (do not buy) with an investment score of 52/100. Treat this as a model signal to review, not a personal buy recommendation.